Pages that link to "Q35234488"

The following pages link to Readers, writers, and erasers: chromatin as the whiteboard of heart disease (Q35234488):

Displaying 43 items.

• Ongoing controversies surrounding cardiac remodeling: is it black and white-or rather fifty shades of gray? (Q26800197) (← links)
• Epigenetic assays for chemical biology and drug discovery. (Q30358152) (← links)
• Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. (Q33705752) (← links)
• Signal-Dependent Recruitment of BRD4 to Cardiomyocyte Super-Enhancers Is Suppressed by a MicroRNA. (Q34534376) (← links)
• MALDI imaging mass spectrometry as a novel tool for detecting histone modifications in clinical tissue samples (Q35903773) (← links)
• Trichostatin A induces a unique set of microRNAs including miR-129-5p that blocks cyclin-dependent kinase 6 expression and proliferation in H9c2 cardiac myocytes (Q38636789) (← links)
• BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries (Q36540974) (← links)
• Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression (Q36812158) (← links)
• Therapeutic targeting of autophagy in cardiovascular disease (Q36913719) (← links)
• Epigenetic regulation in heart failure (Q37114038) (← links)
• Epigenetic intervention with a BET inhibitor ameliorates acute retinal ganglion cell death in mice (Q37714196) (← links)
• Translational Perspective on Epigenetics in Cardiovascular Disease (Q38650827) (← links)
• Histone deacetylase adaptation in single ventricle heart disease and a young animal model of right ventricular hypertrophy (Q38678462) (← links)
• Coordinating Regulation of Gene Expression in Cardiovascular Disease: Interactions between Chromatin Modifiers and Transcription Factors (Q38692469) (← links)
• The nature of the GRE influences the screening for GR-activity enhancing modulators. (Q38697860) (← links)
• Chronic heart failure: Ca(2 ), catabolism, and catastrophic cell death (Q38699105) (← links)
• Epigenetics, Media Coverage, and Parent Responsibilities in the Post-Genomic Era. (Q39014935) (← links)
• Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series (Q39418956) (← links)
• Cardiac Metabolism in Perspective (Q47633793) (← links)
• Epigenetic modulation of vascular diseases: Assessing the evidence and exploring the opportunities (Q51762349) (← links)
• Epigenomes in Cardiovascular Disease. (Q55098768) (← links)
• Actin-related proteins regulate the RSC chromatin remodeler by weakening intramolecular interactions of the Sth1 ATPase (Q57754026) (← links)
• NSD2 promotes ventricular remodelling mediated by the regulation of H3K36me2 (Q58597989) (← links)
• Histones and heart failure in diabetes (Q89207832) (← links)
• Regulation of metabolism by mitochondrial enzyme acetylation in cardiac ischemia-reperfusion injury (Q89753006) (← links)
• Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease (Q90250650) (← links)
• Effect of Saliva Collection Methods on the Detection of Periodontium-Related Genetic and Epigenetic Biomarkers-A Pilot Study (Q90283475) (← links)
• Pharmacological Targeting of BET Bromodomain Proteins in Acute Myeloid Leukemia and Malignant Lymphomas: From Molecular Characterization to Clinical Applications (Q90461512) (← links)
• Epigenetic Control of Mitochondrial Function in the Vasculature (Q90484556) (← links)
• Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia (Q90727256) (← links)
• Direct visualization of cardiac transcription factories reveals regulatory principles of nuclear architecture during pathological remodeling (Q91454853) (← links)
• Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection (Q91642265) (← links)
• HDAC inhibition as a therapeutic strategy in myocardial ischemia/reperfusion injury (Q92067840) (← links)
• Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet (Q92072853) (← links)
• Human chromatin remodeler cofactor, RNA interactor, eraser and writer sperm RNAs responding to obesity (Q92235439) (← links)
• Mechanosensing and Mechanoregulation of Endothelial Cell Functions (Q92378153) (← links)
• Slowing Down Ageing: The Role of Nutrients and Microbiota in Modulation of the Epigenome (Q92494610) (← links)
• Epigenetic Regulation of Excitatory Amino Acid Transporter 2 in Neurological Disorders (Q92535831) (← links)
• The role of environmental exposures and the epigenome in health and disease (Q92610513) (← links)
• De novo variants in exomes of congenital heart disease patients identify risk genes and pathways (Q92666438) (← links)
• Intrauterine programming of obesity and type 2 diabetes (Q92883982) (← links)
• Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics (Q93139190) (← links)
• Understanding the Interplay Between Health Disparities and Epigenomics (Q99711627) (← links)